Review and prospects of international clinical research in critical care medicine in 2023
10.3760/cma.j.cn121430-20240111-00032
- VernacularTitle:2023国际重症医学临床研究回顾与展望
- Author:
Ziqi RONG
1
;
Pengyu LU
;
Wei HUANG
Author Information
1. 大连医科大学附属第一医院重症医学科，辽宁大连 116012
- Keywords:
Critical care medicine;
Breakthrough;
Sepsis;
Septic shock;
Mechanical ventilation;
Cardiac arrest;
Nutrition support
- From:
Chinese Critical Care Medicine
2024;36(2):113-117
- CountryChina
- Language:Chinese
-
Abstract:
The main clinical research advances of critical care in 2023 includes: new trials of Chinese herbal medicine, hydroxocobalamin (vitamin B12), methylene blue as well glucocorticoids have shown the potential to improve outcomes of patients with sepsis and septic shock; international committees launched new global definition and managing recommendations for acute respiratory distress syndrome (ARDS). Besides, a cluster of new evidences has emerged in many aspects as following: fluid control strategy in sepsis (restrictive/liberative), antibiotic infusion strategy (continuous/intermittent), oxygen-saturation targets for mechanical ventilation (conservative/liberative), blood pressure targets after resuscitation from out-of-hospital cardiac arrest (hypotension/hypertension), blood pressure targets after successful stroke thrombectomy (intensive/conventional), and nutritional support strategies (low protein-calories/conventional protein-calories, fasting/persistent feeding before extubation). Thus, given above progress, carrying out high -quality domestic multi-center clinical registration researches, constructing shareable standardized databases, as well raising public awareness of sepsis, should be the essential steps to improve our level of intensive care medicine.
